Trial Profile
Imatinib (Glivec) and imatinib (generic) in patients with chronic myeloid leukaemia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Sep 2015
Price :
$35
*
At a glance
- Drugs Imatinib (Primary)
- Indications Chronic myeloid leukaemia
- Focus Adverse reactions; Therapeutic Use
- 16 Sep 2015 New trial record